Autologous Stem Cell Transplantation in Multiple Myeloma with Renal Failure: Friend or Foe?
Autologous stem cell transplantation (ASCT) is a standard treatment for multiple myeloma (MM), but the clinical response and renal curative effect in MM patients with renal failure (RF) remain controversial. The myeloma kidney disease has different types, and most are due to the direct toxic effects...
Saved in:
Main Authors: | Hongfei Zhong (Author), Xiaojie Xie (Author), Gaosi Xu (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients undergoing autologous stem cell transplantation
by: Jan S. Moreb
Published: (2011) -
Changes in Laboratory Indexes for Multiple Myeloma Patients Before and After Autologous Stem Cell Transplant
by: Zhao R, et al.
Published: (2023) -
Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020) -
Evaluation of success and toxicity of autologous stem cell transplantation in patients with multiple myeloma in the geriatric age group
by: Mehmet Ali Uçar, et al.
Published: (2019) -
Friend and foe
by: A. L. O. E., 1821-1893